Outset Medical to Report Third Quarter 2022 Financial Results Tuesday, November 8, 2022

Rhea-AI Summary

Outset Medical, Inc. (OM) will release its third-quarter financial results on November 8, 2022, after market close. A conference call is scheduled for 2:00 PM PT on the same day, featuring CEO Leslie Trigg and CFO Nabeel Ahmed. Interested parties can register online to receive dial-in information. Outset is known for its innovative Tablo® Hemodialysis System, designed to make dialysis more accessible and efficient, supporting care from hospital to home. This technology integrates water purification and dialysate production, enhancing patient experience and operational efficiency.

Positive

• Innovative technology with the Tablo® Hemodialysis System improving accessibility and efficiency in dialysis care.
• Conference call allows for direct communication of financial results, fostering transparency with investors.

Negative

• None.

SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2022 after the close of trading on Tuesday, November 8, 2022.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Tuesday, November 8, 2022. Those interested in listening to the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221025005763/en/

Jim Mazzola

Vice President, Investor Relations

jmazzola@outsetmedical.com

Brian Johnston

Gilmartin Group

investors@outsetmedical.com

Source: Outset Medical, Inc.

FAQ

When will Outset Medical announce its Q3 financial results?

Outset Medical will announce its Q3 financial results on November 8, 2022.

What time is the Outset Medical conference call scheduled for?

The conference call is scheduled for 2:00 PM Pacific Time on November 8, 2022.

Who will be speaking on the Outset Medical conference call?

CEO Leslie Trigg and CFO Nabeel Ahmed will host the conference call.

Where can I listen to the Outset Medical conference call?

The conference call can be accessed by registering online through Outset Medical's website.

What is the main product of Outset Medical?

Outset Medical's main product is the Tablo® Hemodialysis System, designed to simplify and improve dialysis treatment.